A little over a year ago, Goodrich and several other scientists at Colorado State University dropped what they were doing and devoted their full attention to developing coronavirus vaccines, hoping to end what was then a very young pandemic.
Bringing together talented scientists in one state-of-the-art space is the first step, in a new era of emerging and vector-borne infectious disease research at Colorado State University.
There are approximately 4,700 active research projects at CSU and in the last fiscal year, 78% were funded by federal agencies. Forty-four are COVID-related including the development of four vaccine candidates.
The research team used existing technologies to treat nine plasma and three whole-blood products.
CSU investigators will run tests for up to 45,000 workers and nursing home residents in the state.
Dr. Amy MacNeill and her team are using the vaccinia virus – used as the very first vaccine, for smallpox – to make a vaccine that would protect against coronavirus.
Over the last two months, a team at CSU tested samples from 462 healthcare workers in Colorado.